Paclitaxel Serum Concentrations Linked to Severity of Neuropathy in Breast Cancer Patients
This video highlights a study that examined whether systemic paclitaxel concentrations in breast cancer patients were associated with severity and progression of chemotherapy-induced peripheral neuropathy.
In this video, N. Lynn Henry, MD, PhD, of the University of Utah Huntsman Cancer Institute, discusses a 60-patient study that examined whether systemic paclitaxel concentrations in breast cancer patients were associated with severity and progression of chemotherapy-induced peripheral neuropathy.
Henry was one of the coauthors of the study (abstract P6-11-03), which was presented during a poster session at the 2017 San Antonio Breast Cancer Symposium (SABCS).
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
